New York, September 24, 2020 (GLOBE NEWSWIRE) – Reportlinker. com Announces Release of the Report “Global Nuclear Imaging Devices and Equipment Market Report 2020-30: Covid 19 Impact and Recovery” – https: // www . reportlinkerArraycom / p05967807 /? utm_source = GNW The global market for nuclear imaging devices and apparatus is expected to grow from $ 2. 9 billion in 2019 to $ 2. 3 billion in 2020 at a compound annual expansion rate (CAGR) of -21. 2% Matrix The decline is due basically the COVID-19 epidemic and measures to involve it. The governments of all countries have prioritized the detection of COVID-19 and the images are not routinely used to detect COVID-19. In addition, the top factories of diagnostic imaging devices, such as X-ray formulas, ultrasound formulas, computed tomography (CT) scanners and MRI formulas and / or their components, have been closed lately in order to protect the body. staff and involve propagation. Is expected to marketplaceplaceplaceplaceplaceplaceplaceplaceplaceplacelace recover and grow at a CAGR of 3% from 2021 and succeed in $ 3. 4 billion in 2023. The market for devices and appliances nuclear imaging marketplaceplaceplaceplaceplaceplaceplaceplaceplace consists of sales of imaging devices nuclear and similar services. Nuclear imaging apparatus and devices are used in the diagnosis of radioactive ingredients in patients. The main types of products on the market include SPECT (Single Photon Emission Tomography) formulas (hybrid SPECT and independent SPECT) and hybrid PET formulas. These products are used in a wide variety of medical programs including cardiology, obstetrics / gynecology, vascular programs, urology, and other medical programs. In 2018, North America was the largest region in the market for nuclear imaging devices and devices, laceplaceplaceplaceplaceplaceplaceplace. The Asia-Pacific market for nuclear imaging devices and imaging devices, accepting the cceplaceplaceplaceplaceplaceplaceplaceplace, is expected to record the highest CAGR between 2018 and 2023. In January 2018, Canon acquired Toshiba Medical Systems for $ 6. 21 billion. Canon is expected to focus on developing its medical device business. Toshiba Medical Systems is a medical device company specializing in diagnostic imaging devices, founded in 1948 and based in Tochigi, Japan. The marketplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplacepillo for devices and nuclear imaging devices is limited by strict regulation of medical use through the Nuclear Regulatory Commission (NRC). For example, the NRC asks nuclear imaging licensees to use and purchase radioactive curtains to protect staff and other common people by cutting off unwanted exposures, resulting in the manufacture of a relatively gigantic number. fewer nuclear imaging machines. Hybrid imaging technologies such as Positron Emission Tomography / Computed Tomography (PET / CT), Photon Emission Tomography / Computed Tomography (SPECT / CT) and Positron Emission Tomography (SPECT / CT), and Positron Emission Tomography / magnetic resonance imaging (PET / MRI)) for nuclear medical imaging. These hybrid formulas provide accurate photographs with increased solution and morphological and physiological data in a single verification instance. For example, a SPECT / CT formula for skeletal evaluation provides accurate localization and improves the specificity of the data provided via CT. The United States Nuclear Regulatory Commission (NRC) regulates the manufacture and use of radioactive tissues in nuclear imaging devices, as well as radiation treatment and studies. It has agreements with 37 US states that allow them to regulate the use of certain radioactive tissues by licensing hospitals, clinics, and medical centers. The United States Food and Drug Administration (FDA) also regulates products and procedures that emit radiation. It examines the protection and use of radiopharmaceuticals and machines such as X-rays, which produce radiation but do not produce or use radioactive tissue. The market for nuclear imaging devices and apparatus, receptacles, receptacles, receptacles, receptacles, receptacles, receptacles, is driven by the increasing occurrence and prevalence of diseases such as cancer, central diseases, gastroincheckinal, endocrine and neurological disorders. These diseases are diagnosed at a relatively early stage using nuclear imaging devices compared to other devices. For example, according to the International Agency for Research on Cancer (IARC), cancer cases increased to 18. 1 million new cases and 9. 6 million deaths from cancer in 2018, many of which were diagnosed using devices and nuclear imaging devices. report: https://www. reportlinker. com/p05967807/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning marketplace study solutionceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplaceplace , instantly, in one place.
